With so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.
With the market closed today for Easter, I have picked out three top ASX shares that leading brokers have named as buys recently. Here's why they are bullish on them:
CSL Limited (ASX: CSL)
According to a note out of Wilsons, its analysts have retained their overweight rating and $320 price target on this biotech company's shares. Although the broker expects plasma collection headwinds to stifle its earnings growth in the near term, Wilsons remains positive on its future. Particularly given its strong position in the global plasma market and the strong demand it expects it to continue to experience for plasma-based products. The CSL share price last traded at $263.00.
EROAD Ltd (ASX: ERD)
A note out of Bell Potter reveals that its analysts have put a buy rating and $3.99 price target on this fleet management solution provider's shares. According to the note, the broker is a fan of EROAD due to its consistent revenue and ARPU growth. Bell Potter also sees opportunities for the company to grow the latter metric in the future with new product launches and its growing addressable market. This is particularly the case in the huge North American market. The EROAD share price ended the week at $4.04.
Openpay Group Ltd (ASX: OPY)
Analysts at Shaw and Partners have retained their buy rating and $5.00 price target on this buy now pay later provider's shares. According to the note, the broker was pleased with Openpay's agreement with payments giant FIS Worldpay. Shaw and Partners notes that this is another milestone partnership on the back of its recent ezyVet deal. It feels this further demonstrates the company's ability to integrate into leading global payments providers and augment that with service specialist requirements. The Openpay share price was fetching $2.50 at the end of last week.
